You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent intraocular melanoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Iris Melanoma Trial in

Completed
Has Results
  • Ciliary Body and Choroid Melanoma, Medium/Large Size
  • +5 more
  • Cixutumumab
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
  • +1 more
Feb 5, 2020

Definity for Ultrasound of Intraocular Tumors

Withdrawn
  • Ocular Melanoma
    • Atlanta, Georgia
      Emory Eye Center
    Feb 7, 2022

    Uveal Melanoma, Uveal Melanoma, Posterior, Medium/Large Size, Eye Cancer, Intraocular Melanoma Trial in Stockholm (Melatonin)

    Not yet recruiting
    • Uveal Melanoma
    • +2 more
    • Stockholm, Sweden
      St. Erik Eye Hospital
    Aug 14, 2022

    Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)

    Not yet recruiting
    • Recurrent Metastatic Melanoma
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Jul 29, 2022

    Brain Metastases, Glioma of Brain, Brain Tumor Trial in Los Angeles (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,

    Recruiting
    • Brain Metastases
    • +3 more
    • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
    • Bevacizumab Injection
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Nov 12, 2022

    Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

    Active, not recruiting
    Has Results
    • Metastatic Melanoma
    • +22 more
    • Ipilimumab
    • +3 more
    • Birmingham, Alabama
    • +24 more
    Jan 19, 2023

    Unresectable, Recurrent or Metastatic Melanoma, Untreated Mucosal or Acral Lentiginous Melanoma Trial in China (MGD013)

    Terminated
    • Unresectable, Recurrent or Metastatic Melanoma
    • Untreated Mucosal or Acral Lentiginous Melanoma
    • Beijing, Beijing, China
    • +12 more
    Apr 12, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +20 more
    • Neoantigen Peptide Vaccine
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 7, 2022

    Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

    Completed
    • Male Breast Cancer
    • +7 more
    • propranolol hydrochloride
    • Correlative Studies
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 4, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma Trial in Rochester (Anti-PD-L1 Monoclonal Antibody

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +3 more
    • Anti-PD-L1 Monoclonal Antibody IMC-001
    • Punch Biopsy
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Buffalo (Recombinant Human Hsp110-gp100

    Terminated
    • Recurrent Melanoma
    • +3 more
    • Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
    • Laboratory Biomarker Analysis
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 20, 2022

    Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Lung, Metastatic Melanoma Trial in Rochester

    Not yet recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +4 more
    • Aerosol Sargramostim
    • +5 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 30, 2023

    Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)

    Active, not recruiting
    • Brain and Central Nervous System Tumors
    • +9 more
    • DNA analysis
    • +4 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Oct 28, 2021

    Recurrent Melanoma Trial in Columbus (selinexor, Correlative studies)

    Active, not recruiting
    • Recurrent Melanoma
    • Columbus, Ohio
      Arthur G. James Cancer Hospital and Solove Research Institute at
    Sep 5, 2022

    Locally Advanced Unresectable or Metastatic Melanoma Trial in United States (Selinexor, Pembrolizumab)

    Recruiting
    • Locally Advanced Unresectable or Metastatic Melanoma
    • Los Angeles, California
    • +12 more
    Jun 30, 2022

    Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

    Active, not recruiting
    • Adult Grade III Lymphomatoid Granulomatosis
    • +23 more
    • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Newly Diagnosed or Recurrent Metastatic Melanoma Patients, Malignant Brain Tumors Trial in New York (PET scan with

    Active, not recruiting
    • Newly Diagnosed or Recurrent Metastatic Melanoma Patients
    • Malignant Brain Tumors
    • PET scan with 124I-cRGDY-PEG-dots
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Sep 13, 2022

    SCLC, Malignant Melanoma, Sarcoma Trial (GD2-SADA:177Lu-DOTA Complex)

    Not yet recruiting
    • SCLC
    • +2 more
    • GD2-SADA:177Lu-DOTA Complex
    • (no location specified)
    May 4, 2022

    Cervical Cancer, Prostate Cancer Metastatic, Breast Cancer Trial (²¹²Pb-DOTAM-GRPR1)

    Recruiting
    • Cervical Cancer
    • +5 more
    • Chicago, Illinois
    • +3 more
    Jan 24, 2023

    Intraocular Melanoma, Melanoma (Skin), Metastatic Cancer Trial in United States (melphalan, regional chemo, systemic chemo)

    Completed
    • Intraocular Melanoma
    • +2 more
    • Santa Monica, California
    • +11 more
    Jun 15, 2021

    Complications and Recurrences After Mohs Micrographic Surgery

    Recruiting
    • Skin Cancer
    • +9 more
    • Mohs surgery
    • Slow Mohs surgery
    • Maastricht, Netherlands
      Maastricht University Medical Center+
    Aug 23, 2023

    Metastatic Melanoma, Recurrent Cutaneous Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (Ibrutinib,

    Active, not recruiting
    Has Results
    • Metastatic Melanoma
    • +2 more
    • Los Angeles, California
    • +12 more
    Jul 27, 2022

    Melanoma Trial in United Kingdom (ATL001, Checkpoint Inhibitor)

    Recruiting
    • Melanoma
    • ATL001
    • Checkpoint Inhibitor
    • Cambridge, United Kingdom
    • +6 more
    Jul 23, 2021

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,

    Recruiting
    • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    • +26 more
    • Biopsy
    • +5 more
    • Newark, Delaware
    • +52 more
    Feb 2, 2023